Matt Marin, Founding Partner, Marin & Murphy Law Firm
FIND OUT IF YOUR CASE QUALIFIES
Free Confidential Consultation No Fee Unless There Is a Recovery

Super Lawyers® 2014–2024CALL 24/7(888) 348-2735

Olympus Scope — Infection Claims

Hospitalized With an Infection After a Scope Procedure?

If you were told it was “just a complication,” Olympus’s federal guilty plea — and $85 million in penalties — tell a different story. In two minutes, you can know whether your case qualifies.

ACTIVE LITIGATION. 250+ patients · most recent filing: June 2026 · deadlines vary by state — some as short as one year.

Were you hospitalized with an infection within 30 days of an endoscopy or scope procedure?

Yes — See If My Case Qualifiesfree · takes 2 minutes
I think so / not sure

Free · confidential · no fee unless there is a recovery · answering doesn’t commit you to anything. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted.

Attorney Matthew T. MarinPrefer to talk it through? (888) 348-2735 — free and confidential.

Attorneys Stefanie A. Murphy and Matthew T. Marin of Marin & Murphy Law Firm

Stefanie A. Murphy & Matthew T. Marin

Partners

You’ll get a straight answer even if it’s “you don’t qualify.” Everything you share is confidential — even if you never hire us. No fee unless there is a recovery; costs are advanced and reimbursed only out of a recovery. If you do qualify, our Olympus scope litigation team requests the medical and hospital records — you don’t chase them.

Qualification depends on what the medical records show — the scope involved, the infection, and the timing. We’ll review them and give you a straight answer either way.

Olympus scope lawsuit case values vary substantially based on the specific facts of each case. The primary factors are severity of infection, length of hospitalization, IV antibiotic regimen, presence of organ damage, permanent disability, and whether the case involves death. In Bigler v. Olympus (King County Superior Court, July 24, 2017) — the only case in this litigation tried to verdict — the jury found Olympus liable for failure to warn and rejected the design-defect claim.

It awarded $6.6 million to Virginia Mason Medical Center for the hospital’s own losses, and $1 million to the patient’s family, which the hospital was ordered to pay. The $6.6 million is a hospital’s commercial recovery, not a patient award, and is not an indicator of individual case value. As of April 25, 2026, no MDL has been filed and no settlement has been reached in this litigation; therefore no settlement history exists against which to predict outcomes.

That verdict was obtained by the plaintiffs’ trial counsel in that case — not by Marin & Murphy Law Firm, which had no role in the Bigler litigation. In January 2018 the court granted the patient’s family a new trial after finding that Olympus had withheld internal safety records, and the family’s claims were later resolved by confidential settlement. It is cited here as public-record context only; results vary, and no outcome in another case predicts or guarantees a similar result in any other matter.

Past results do not guarantee future outcomes, and individual case values vary substantially.

Get a Free Case Evaluation — Marin & Murphy Law Firm

Call (888) 348-2735 or use our online intake form. We review your records and advise on your case value at no cost.

⚖️

See if you qualify

A few quick questions about your scope procedure, the infection you were diagnosed with, and whether you were hospitalized. This is the initial intake screening, not a full case review. Most people finish in about two minutes.

  • 🔒 Confidential
  • No obligation
  • ⏱ ~2 minutes

Get started

Marin & Murphy Law Firm · Free & confidential · Stop messages anytime

What Factors Determine the Value of an Olympus Scope Lawsuit?

Every Olympus scope lawsuit is valued based on the specific facts of the injury. The primary factors that drive case value are: Severity of infection. A straightforward infection that responded to IV antibiotics and resolved within a week is valued differently from an infection that caused organ failure, extended ICU admission, or permanent disability. The more severe and lasting the injury, the higher the case value.

Hospitalization length. The length of inpatient hospitalization is a direct proxy for severity. A 3—5 day hospitalization for a confirmed infection with full recovery represents a baseline qualifying case. Extended hospitalizations — especially those involving ICU admission — significantly increase case value. Organ damage. If the infection caused damage to the kidneys, liver, heart, or other organs, the case value increases substantially.

Permanent organ damage is among the most significant value drivers in this litigation. Wrongful death. Cases where the patient died as a result of the scope-related infection — including cases where the infection was a contributing cause of death alongside underlying medical conditions — are among the most serious cases in this litigation. The Virginia Mason $6.6 million jury verdict arose from a wrongful death claim.

Permanent disability. Cases where the patient can no longer walk, perform basic activities of daily living, or maintain employment as a result of the infection are among the most serious cases in this litigation. Catastrophic injury cases are typically grouped with wrongful-death cases in the most serious tier. Each case’s value depends on its specific facts and the legal theories pursued. IV antibiotic treatment. The receipt of IV antibiotic treatment during inpatient hospitalization is a required qualifying criterion — but the nature of the antibiotic regimen also affects value.

Patients who required last-resort antibiotics such as colistin or tigecycline for CRE infections have higher-value cases than those whose infections responded to first-line agents.

Lost income and medical expenses. Standard economic damages for lost wages, future earning capacity, and past and future medical expenses are calculated and added to non-economic damages. For catastrophic and death cases, these can reach substantial amounts independently. Device model. Whether the procedure used a recalled device model (TJF-Q180V, TJF-Q190V) or a recalled accessory (MAJ-891) is a factor in establishing direct device-level causation and may affect value.

How Are Olympus Scope Lawsuit Cases Tiered by Severity?

Olympus scope lawsuit cases can be grouped into severity tiers based on the nature and extent of the injury. These tiers describe the categories of cases — they are not predictions of any specific dollar value. Each case’s value depends on its specific facts and the legal theories pursued. Standard qualifying case: A confirmed Olympus scope procedure on or after January 1, 2015; a confirmed infection; inpatient hospitalization; IV antibiotic treatment; and full recovery.

Serious injury tier: Cases involving organ damage, extended ICU stays, or infections requiring last-resort antibiotics. These cases involve more extensive medical documentation and longer recovery. Wrongful death tier: Cases where the patient died from, or with a meaningful contribution from, the scope-related infection. Causation does not require that the infection was the sole cause of death; a contributing cause may be sufficient.

Catastrophic injury tier: Cases where the patient sustained permanent, life-altering disability as a result of the infection — including patients who can no longer walk or perform basic daily functions. Public trial verdict: The only case tried to verdict, Bigler v. Olympus (King County, July 24, 2017), produced $6.6 million for Virginia Mason’s own losses and $1 million for the patient’s family — a hospital recovery, not a measure of what an individual claim is worth.

(Source: King County Superior Court, Seattle, WA.) This is the primary public data point for valuing serious Olympus scope claims. Individual settlement amounts from co-counsel agreement cases are confidential and are not cited here. MDL trajectory: individual cases are proceeding in federal and state courts.

What Is the Olympus Criminal Record and Why Does It Matter for Settlement Value?

Olympus Medical Systems Corporation and former senior executive Hisao Yabe pleaded guilty in December 2018 to three federal criminal counts of distributing misbranded medical devices, paying $85 million in penalties and admitting a failure to file FDA-required adverse-event reports. (Source: DOJ press release, December 10, 2018; Case No. 2:18-cr-00727-SRC, U.S. District Court, D.N.J.) The criminal record matters for settlement value in three ways.

First, it eliminates the standard defense argument that the manufacturer had no knowledge of the defect — the guilty plea is an admission of knowledge and reporting failures. Second, it may bear on the causation analysis: Olympus cannot credibly argue in front of a jury that its devices did not cause infections while simultaneously having pled guilty to failing to report those infections to the FDA. Third, Olympus cannot use a bankruptcy restructuring to escape this liability — the criminal judgment against a corporate subsidiary means the parent company’s exposure cannot be discharged through bankruptcy.

Whether and how these factors affect available defenses, causation, or recovery is determined case-by-case by the court applying the relevant law to the facts of each matter. Insurance carriers and settlement counsel for Olympus understand that the trial risk on causation is substantially higher than in cases where the defendant did not plead guilty. For more background on the full criminal and regulatory timeline, see the Olympus criminal history page.

What Injuries Qualify and How Do They Affect Case Value?

Case value tracks directly to injury tier. Standard infection requiring hospitalization and IV antibiotics is the baseline qualifying case category. Sepsis with organ involvement is a more serious tier requiring more extensive documentation. Extended ICU admission, significant organ damage, and permanent impairment represent a more serious tier still. Wrongful death and catastrophic permanent disability are the most serious tier.

Each case’s value depends on its specific facts and the legal theories pursued. The confirmed intake criteria require: procedure on or after January 1, 2015; Olympus bronchoscope, upper GI endoscope, or colonoscope; confirmed infection; inpatient hospitalization; IV antibiotic treatment; infection within 30 days of procedure. These criteria establish the floor for case qualification. Every criterion met at a more severe level may place the case in a more serious tier.

Patients who developed CRE (Carbapenem-Resistant Enterobacteriaceae) infections have the highest value cases within the infection tier because CRE carries a 40—50% mortality rate and requires last-resort antibiotic treatment. (Source: CDC MMWR Vital Signs, March 5, 2013.) Patients who developed NDM-1-producing E. coli or other multidrug-resistant organisms are in the same tier. Standard Klebsiella or E. coli infections that responded to first-line antibiotics are qualifying but at lower value.

Confirm Your Case Value — Free Evaluation

Contact Marin & Murphy today for a free case evaluation: (888) 348-2735

How Long Until Olympus Scope Cases Resolve?

The MDL timeline has been confirmed based on information available as of April 2026. Cases are currently proceeding as individual lawsuits in federal and state courts. Because these cases proceed as individual lawsuits, timelines vary by case — placing the first trials in Q2—Q4 2028 under this timeline. Global settlement typically follows individual trials, adding another 12—24 months for full resolution. For patients: this means a realistic resolution timeline of 2—5 years from now, with compensation distributed as cases are resolved in waves.

Patients who file early are positioned better in the MDL queue and have stronger documentation of their injuries. The filing deadline is set by the statute of limitations from the date of injury — not by the MDL formation date. Tennessee patients have one year; most other states have 2—3 years. For the complete background on the litigation and all qualifying criteria, see the complete guide to the Olympus scope lawsuit.

Frequently Asked Questions

Sources
  • King County Superior Court, Seattle, WA. Bigler v. Olympus verdict, July 24, 2017. $6.6 million to Virginia Mason Medical Center; $1 million to the patient’s family.
  • DOJ press release. December 10, 2018. justice.gov. Case No. 2:18-cr-00727-SRC, D.N.J.
  • CDC MMWR Vital Signs. March 5, 2013. CRE 40—50% bloodstream mortality. cdc.gov/mmwr
  • FDA Recall Z-0905-2025. December 18, 2024. MAJ-891 Forceps/Irrigation Plug. accessdata.fda.gov
  • Olympus Urgent Field Safety Notice. October 14—17, 2025. 2 deaths, 5 injuries. Prior protocols insufficient. 10x magnification required.
  • Ross AS, et al. Gastrointest Endosc. 2015 Sep;82(3):477-83. PMID 26092616.
  • van der Ploeg K, et al. Gut. 2024;73(4):613-621. PMID 38182137.
  • Bomman S, et al. Clinical Endoscopy. January 2022. PMC8831410.
  • JPML Pending MDL Dockets, January 2026. jpml.uscourts.gov
  • Senate HELP Committee. “Preventable Tragedies.” January 13, 2016. help.senate.gov

Attorney Advertising. Marin & Murphy Law Firm. Prior results do not guarantee a similar outcome.